Polymyositis – Diagnostics – Overview of Information and Clinical Research

Polymyositis is a rare disease that causes chronic inflammation in multiple muscles throughout the body, leading to progressive weakness and a range of complications that can significantly affect daily life. Understanding how doctors diagnose this condition is the first step toward managing its symptoms and preventing serious health problems.

Introduction: Who Should Undergo Diagnostics and When

If you notice unexplained muscle weakness that gradually gets worse over several weeks or months, it’s important to see a healthcare provider. Polymyositis typically affects adults between the ages of 30 and 60, though it can occur at any age. Women are twice as likely to develop this condition compared to men.^[1]^[2]

You should seek medical attention if you experience difficulty performing everyday activities that were once easy. This might include trouble climbing stairs, rising from a seated position, lifting objects above your head, or standing up from a chair. These challenges often indicate that the muscles closest to the center of your body—such as those in your shoulders, hips, thighs, upper arms, back, and neck—are becoming weak.^[1]

Some symptoms require immediate medical evaluation. If you develop difficulty swallowing, trouble breathing, or shortness of breath, you should go to the emergency room or call your local emergency services number right away. These symptoms can lead to life-threatening complications such as aspiration pneumonia (when food or liquid enters the lungs) or respiratory failure.^[1]^[2]

People who already have other autoimmune diseases should be particularly alert to symptoms of polymyositis. If you have been diagnosed with lupus (a disease where the immune system attacks various body tissues), rheumatoid arthritis (chronic joint inflammation), scleroderma (skin and tissue hardening), or Sjögren’s syndrome (which affects moisture-producing glands), your risk of developing polymyositis is higher. Additionally, certain viral infections including COVID-19, influenza, the common cold, and HIV can trigger this muscle disease.^[1]^[4]

⚠️ Important

Polymyositis symptoms may develop gradually, and many people have the disease for months or even years before it is recognized. Depression and a general feeling of unhappiness can be noticeable even before any sign of muscle weakness appears. If you feel persistently tired, experience unexplained weight loss, or have a low-grade fever along with muscle tenderness, don’t dismiss these symptoms as simply aging or stress. Early diagnosis and treatment can significantly improve your quality of life and prevent severe complications.

The muscle weakness in polymyositis tends to affect both sides of your body equally and progresses gradually. You might notice that you have trouble raising your arms to comb your hair, difficulty getting out of bed in the morning, or problems swallowing food. Your voice might also change, becoming nasal or deeper in quality if the throat muscles are affected.^[3]^[5]

Diagnostic Methods for Identifying Polymyositis

Diagnosing polymyositis can be challenging because there is no single simple test that confirms the disease. Doctors must use a combination of methods to rule out other conditions and establish a definitive diagnosis. The process often takes time, as healthcare providers need to carefully evaluate various test results and physical findings.^[6]

Physical Examination and Medical History

Your healthcare provider will begin by taking a complete medical history and performing a thorough physical examination. They will ask detailed questions about when your symptoms began, how they have progressed, and which activities have become difficult. The doctor will examine the muscles that feel weak and test your muscle strength by asking you to perform certain movements or motions. They will observe how you stand up from a chair, raise your arms, and perform other basic activities.^[1]^[15]

Blood Tests

Blood tests are essential diagnostic tools for polymyositis. These tests can detect elevated levels of muscle enzymes that leak into the bloodstream when muscle tissue is damaged. The most important enzyme measured is creatine phosphokinase (CPK or CK), which can be significantly elevated in people with polymyositis—sometimes reaching levels of 5,000 or higher when normal levels are much lower. Other muscle enzymes that may be measured include aldolase and myoglobin.^[1]^[7]

Blood tests can also detect specific autoantibodies—proteins that the immune system mistakenly produces to attack the body’s own tissues. These myositis-specific and myositis-associated autoantibodies help doctors understand the type and severity of the disease. Different antibodies can indicate whether you might have complications affecting other organs, such as the lungs or heart.^[7]^[9]

Electromyography (EMG)

Electromyography, commonly called EMG, is a test that measures the electrical activity of your muscles. During this procedure, a thin needle electrode is inserted through the skin into the muscle being tested. As you relax or tighten the muscle, the electrical activity is measured and recorded. Changes in the pattern of electrical activity can confirm that you have a muscle disease rather than a nerve problem. The doctor can test different muscles to understand how widespread the disease is.^[1]^[9]

Some patients find the EMG uncomfortable because the sensations can be unexpected. It’s helpful to ask your doctor detailed questions beforehand about what to expect, as being too tense during the test can make it difficult to get accurate readings. Understanding the process in advance helps you relax, which is important for obtaining reliable results.^[15]

Magnetic Resonance Imaging (MRI)

An MRI (magnetic resonance imaging) scan uses powerful magnets and radio waves to create detailed images of your muscles and other soft tissues. This non-invasive test can show areas of inflammation and swelling in the muscles over a large area of the body. Unlike a muscle biopsy that examines only a small piece of tissue, an MRI provides information about inflammation patterns throughout multiple muscle groups. This helps doctors determine which muscles are most severely affected and can guide them in choosing the best location for a biopsy if one is needed.^[1]^[9]

Muscle Biopsy

A muscle biopsy is often necessary to confirm the diagnosis of polymyositis. During this minor surgical procedure, a small piece of muscle tissue is removed for laboratory analysis. The tissue sample is examined under a microscope to look for specific patterns of inflammation, muscle fiber damage, and the presence of immune cells attacking the muscle. In polymyositis, the inflammation primarily affects the endomysial layers (the innermost connective tissue surrounding individual muscle fibers) rather than other layers.^[1]^[4]^[9]

The biopsy can also reveal abnormalities such as certain proteins or enzyme deficiencies that help distinguish polymyositis from other muscle diseases. For example, it can help doctors differentiate polymyositis from dermatomyositis (which involves different muscle layers and causes a skin rash) or inclusion body myositis (which progresses more slowly and primarily affects older individuals).^[1]^[4]

Additional Tests to Rule Out Other Conditions

Because polymyositis can affect organs beyond the muscles, your doctor may order additional tests to evaluate your overall health and check for complications. These might include:

Electrocardiogram (ECG) to check for heart rhythm problems, as polymyositis can sometimes affect the heart muscle
Chest X-ray and CT scan to look for lung involvement, which occurs in some patients and can cause breathing difficulties
Pulmonary function tests to measure how well your lungs are working
Esophageal swallowing studies to evaluate difficulty swallowing, which can lead to malnutrition or aspiration

These tests help doctors understand the full extent of the disease and plan appropriate treatment.^[7]

⚠️ Important

People with polymyositis must be watched carefully for signs of cancer. Studies have shown that some patients with inflammatory muscle diseases have an increased risk of developing certain cancers. Your healthcare provider will likely recommend regular cancer screening as part of your ongoing care. This doesn’t mean you will definitely develop cancer, but vigilant monitoring is an important part of managing polymyositis.

Nerve Conduction Studies

Sometimes doctors perform nerve conduction studies along with the EMG. These tests measure how well and how fast electrical signals travel through your nerves. This helps doctors determine whether your symptoms are caused by a muscle problem (like polymyositis) or a nerve problem. In polymyositis, nerve conduction is typically normal, which helps distinguish it from nerve disorders that can cause similar symptoms.^[15]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or approaches for managing polymyositis. If you’re interested in participating in a clinical trial, you’ll need to undergo specific diagnostic tests to determine whether you meet the study’s requirements. These criteria help researchers ensure that the trial participants have confirmed diagnoses and comparable disease characteristics.^[13]

The standard diagnostic tests for clinical trial enrollment typically include all the basic tests used to diagnose polymyositis in regular clinical practice. Blood tests measuring muscle enzyme levels (particularly CPK), electromyography, MRI scans, and muscle biopsies are commonly required. However, clinical trials may have additional specific requirements based on the treatment being studied.^[9]

For example, a trial might require that your CPK levels be above a certain threshold, or that your MRI shows active inflammation in specific muscle groups. Some trials may require testing for particular autoantibodies to ensure that participants have similar disease subtypes. Trials testing medications for lung complications might require pulmonary function tests showing a certain degree of lung involvement.^[7]

Many clinical trials also require baseline measurements of muscle strength and function before treatment begins. This allows researchers to measure how much improvement occurs with the new treatment. These functional assessments might include timed tests such as how long it takes you to walk a certain distance, rise from a chair multiple times, or lift your arms to a specific height.^[13]

Additionally, trials often exclude patients with certain other health conditions or those taking specific medications that might interfere with the study results. Before enrolling, you’ll undergo a comprehensive health evaluation to ensure you meet all the inclusion criteria and don’t have any conditions listed in the exclusion criteria. This thorough screening process protects your safety and helps ensure that the trial produces reliable scientific results.^[11]

If you’re considering participating in a clinical trial for polymyositis, discuss the potential benefits and risks with your healthcare provider. Clinical trials offer access to cutting-edge treatments that might not yet be available to the general public, but they also involve uncertainties about effectiveness and potential side effects. Your doctor can help you understand whether a particular trial is appropriate for your situation and what diagnostic tests you’ll need to complete for enrollment.^[13]

Prognosis and Survival Rate

Prognosis

The outlook for people with polymyositis varies considerably depending on several factors. Response to treatment differs between individuals, with some patients responding fairly well to therapy while others have more severe disease that doesn’t respond adequately to available treatments. Many people, especially when diagnosed and treated early, can achieve significant improvement in muscle strength and function.^[14]

Several factors affect prognosis in polymyositis. Poor prognostic indicators include difficulty swallowing (dysphagia) or voice changes (dysphonia), as these suggest involvement of throat and respiratory muscles. Patients with these symptoms are more likely to require aggressive treatment with multiple immunosuppressive medications. Lung disease, particularly when associated with specific antibodies like anti-MDA-5, carries a particularly poor outlook despite current treatments.^[7]^[11]

The timing of treatment also influences outcomes. When treatment begins earlier in the course of the disease, it tends to be more effective and leads to fewer complications. However, polymyositis requires long-term management, and many patients need ongoing treatment with steroids or immunosuppressive medications to keep the disease under control. Some people may be able to gradually reduce or discontinue medication if their disease becomes inactive, while others require lifelong maintenance therapy.^[9]^[13]

Survival Rate

Historical data suggests that approximately one in five people (20%) with polymyositis may die within five years of developing the condition. However, this statistic reflects outcomes across a broad population and doesn’t account for individual circumstances or advances in treatment approaches.^[7]

The major causes of death in polymyositis are complications related to cancer, lung disease, malnutrition, pneumonia (often from aspiration of food or liquid into the lungs), and respiratory failure due to severe weakness of breathing muscles. Proper management focused on preventing these complications can significantly improve survival outcomes.^[7]

It’s important to note that many people with polymyositis live for many years after diagnosis with appropriate treatment and monitoring. Children with juvenile forms of the disease often have better outcomes and may recover completely, not requiring ongoing treatment. Most adults will need continued immunosuppressive therapy to control the disease, but with proper management, many can maintain a reasonable quality of life despite the challenges of living with a chronic illness.^[7]^[14]

#1 Clinical Trials Search in Europe